Virgin Health Bank has established a stem-cell bank in Qatar, in partnership with the Qatar Science & Technology Park.

Qatar parents will be able to have their new born babies’ stem cells collected, processed and cryogenically stored.

The stem cells are obtained from the blood remaining in the umbilical cord after birth and are already being used in treatments for 85 different medical conditions.

Additionally stem cells are a major focus of medical research around the world and this is expected to add to the number of therapies available.

“Stem cells have already proven useful for fighting leukaemia, and are one of the most promising areas for future medical breakthroughs,” said Dr Ghalia Al Thani, Minister of Health.

Virgin Health Bank and Qatar’s medical authorities are exploring the use of the umbilical cord-blood stem cell bank as part of a national public-health program.

Such a program would create the world’s first comprehensive source of stem cells for the indigenous Middle Eastern population and would for example, make it easier for clinicians to source a matched tissue typed stem cell unit when a transplant is needed.

Umbilical cord-blood stem cell transplants are increasingly being used in preference to bone marrow for conditions such as leukaemia and thalassemia. Evidence shows that umbilical cord blood stem-cell transplants result in fewer complications, reduced occurrences of graft-versus-host syndrome, and importantly, they are more readily available.

Because Virgin Health Bank’s process collects stem cells from ordinary umbilical cords, ethical considerations related to other sources of stem cells are avoided. Its model has been deemed compliant with Shariah law by a Qatar-based Islamic scholar.

Virgin Health Bank with the support of local institutes expects to start storing cord blood stem cell samples from Qatar within the next few months. The company, which was launched in the UK in 2007, will relocate its international headquarters to Qatar Science & Technology Park where it will build a state of the art processing and cryogenic storage facility.

“We are delighted to have the opportunity to use our skills and technology to help realise the current and future benefits of stem cell therapies for the people of Qatar and to be working in partnership with QSTP, the Qatar Foundation and Qatar’s medical authorities to accomplish this,” added David Macauley, chief of Virgin Health Bank.-TradeArabia News Service